Cargando…

Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan

(J Diabetes Invest, doi: 10.1111/j.2040‐1124.2012.00224.x, 2012) Aims/Introduction:  The Japanese Red Cross Society introduced measurement of glycated albumin (GA) for all blood donors as a glycemic control marker. The GA levels were examined by sex and age. Materials and Methods:  GA was measured i...

Descripción completa

Detalles Bibliográficos
Autores principales: Araki, Takeshi, Ishikawa, Yoshihide, Okazaki, Hitoshi, Tani, Yoshihiko, Toyooka, Shigetake, Satake, Masahiro, Miwa, Umeo, Tadokoro, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015427/
https://www.ncbi.nlm.nih.gov/pubmed/24843613
http://dx.doi.org/10.1111/j.2040-1124.2012.00224.x
_version_ 1782315336338505728
author Araki, Takeshi
Ishikawa, Yoshihide
Okazaki, Hitoshi
Tani, Yoshihiko
Toyooka, Shigetake
Satake, Masahiro
Miwa, Umeo
Tadokoro, Kenji
author_facet Araki, Takeshi
Ishikawa, Yoshihide
Okazaki, Hitoshi
Tani, Yoshihiko
Toyooka, Shigetake
Satake, Masahiro
Miwa, Umeo
Tadokoro, Kenji
author_sort Araki, Takeshi
collection PubMed
description (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2012.00224.x, 2012) Aims/Introduction:  The Japanese Red Cross Society introduced measurement of glycated albumin (GA) for all blood donors as a glycemic control marker. The GA levels were examined by sex and age. Materials and Methods:  GA was measured in 3.14 million blood donors who donated between April 2009 and March 2010. For the reference range for GA, values that were three times the reference range for glycated hemoglobin (Japan Diabetes Society value) were used. All donors were notified of their GA levels. For repeat donors, a comparison was made between the GA levels at the first and second donations to verify the GA change after notification. Results:  The mean GA was significantly lower in males than in females in donors aged <60 years. The mean GAs of both sexes increased with age and reached the same level of 14.8% in their 60s. The percentage of donors with prediabetes/diabetes (GA ≥16.5%) was 2.8% in males and 2.3% in females. In the normal high group (15.6% ≤ GA < 16.5%), the mean GA at the second donation was lower by 0.20% than at the first donation. In 42.4% of these donors, GA decreased to the normal range at the second donation. Conclusions:  Overall, 2.7% of otherwise healthy Japanese blood donors had a high GA (GA ≥16.5%). Donor blood screening for GA represents an effective measure to identify people at risk of diabetes. The decrease in the GA level after GA notification might indicate the potential usefulness of this strategy to improve glycemic control among people with high GA.
format Online
Article
Text
id pubmed-4015427
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-40154272014-05-19 Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan Araki, Takeshi Ishikawa, Yoshihide Okazaki, Hitoshi Tani, Yoshihiko Toyooka, Shigetake Satake, Masahiro Miwa, Umeo Tadokoro, Kenji J Diabetes Investig Articles (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2012.00224.x, 2012) Aims/Introduction:  The Japanese Red Cross Society introduced measurement of glycated albumin (GA) for all blood donors as a glycemic control marker. The GA levels were examined by sex and age. Materials and Methods:  GA was measured in 3.14 million blood donors who donated between April 2009 and March 2010. For the reference range for GA, values that were three times the reference range for glycated hemoglobin (Japan Diabetes Society value) were used. All donors were notified of their GA levels. For repeat donors, a comparison was made between the GA levels at the first and second donations to verify the GA change after notification. Results:  The mean GA was significantly lower in males than in females in donors aged <60 years. The mean GAs of both sexes increased with age and reached the same level of 14.8% in their 60s. The percentage of donors with prediabetes/diabetes (GA ≥16.5%) was 2.8% in males and 2.3% in females. In the normal high group (15.6% ≤ GA < 16.5%), the mean GA at the second donation was lower by 0.20% than at the first donation. In 42.4% of these donors, GA decreased to the normal range at the second donation. Conclusions:  Overall, 2.7% of otherwise healthy Japanese blood donors had a high GA (GA ≥16.5%). Donor blood screening for GA represents an effective measure to identify people at risk of diabetes. The decrease in the GA level after GA notification might indicate the potential usefulness of this strategy to improve glycemic control among people with high GA. Blackwell Publishing Ltd 2012-06-26 2012-12-20 /pmc/articles/PMC4015427/ /pubmed/24843613 http://dx.doi.org/10.1111/j.2040-1124.2012.00224.x Text en © 2012 Asian Association for the Study of Diabetes and Wiley Publishing Asia Pty Ltd
spellingShingle Articles
Araki, Takeshi
Ishikawa, Yoshihide
Okazaki, Hitoshi
Tani, Yoshihiko
Toyooka, Shigetake
Satake, Masahiro
Miwa, Umeo
Tadokoro, Kenji
Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan
title Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan
title_full Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan
title_fullStr Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan
title_full_unstemmed Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan
title_short Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan
title_sort introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in japan
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015427/
https://www.ncbi.nlm.nih.gov/pubmed/24843613
http://dx.doi.org/10.1111/j.2040-1124.2012.00224.x
work_keys_str_mv AT arakitakeshi introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan
AT ishikawayoshihide introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan
AT okazakihitoshi introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan
AT taniyoshihiko introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan
AT toyookashigetake introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan
AT satakemasahiro introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan
AT miwaumeo introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan
AT tadokorokenji introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan
AT introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan